drugset / Trial / NCT02944175

Cerebral Oxygenation and Metabolism After Reversal Of Rocuronium: Comparison Between Sugammadex Versus Neostigmine

NCT02944175

Unknown 40 enrolled Mansoura University
RandomizedParallel-groupTriple-blindSupportive care

Summary

Cholinesterase inhibitors such as Neostigmine and Edrophonium have been used to reverse neuromuscular blockade after surgery. However, these drugs have a relatively slow onset and have adverse effects associated with stimulation of muscarinic receptors. In addition, neostigmine cannot be used to reverse profound blockade. Anesthetics may exert their effects on various facets of cerebral function such as cerebral metabolic rate (CMRO2), cerebral blood flow (CBF), cerebral blood flow-metabolism coupling, intra cranial pressure (ICP), autoregulation, vascular response to CO2 and brain electrical activity. The net result of all these effects of the anaesthetic agents combined with their systemic effects may prove beneficial or detrimental to an already diseased brain. In neurosurgical patients, clear and rapid recovery is required to early assess the neurological status and to maintain the cerebral oxygenation and metabolism within the normal physiological values which may be saved by sugammadex.

Timeline

Start
2016-07
Primary completion
2019-09-01
Completion
2019-10-01

Drugs

EvaluationDrugModalityDoseRoute
Comparator Neostigmine Other / unclassified 0.05 mg/kg Intravenous
Subject Sugammadex Other / unclassified 2 mg/kg Intravenous
Comparator Atropine Other / unclassified 0.02 mg/kg Intravenous

Indications